Smith Brendan
Insider CIK 1857492 · CRSP Chief Financial Officer · TBIO Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2023-02-21 | 2023-02-22 | 1,392 | $48.26 | $67.2K | 5,072 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2023-02-18 | 2023-02-22 | 3,825 | — | $0 | 11,475 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2023-02-18 | 2023-02-22 | 3,825 | — | $0 | 6,464 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2022-10-17 | 2022-10-18 | 1,111 | $55.76 | $61.9K | 2,639 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-10-14 | 2022-10-18 | 3,750 | — | $0 | 11,250 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-10-14 | 2022-10-18 | 3,750 | — | $0 | 3,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-10-07 | 2022-10-12 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-08-16 | 2022-08-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-02-18 | 2022-02-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-02-18 | 2022-02-22 | 15,300 | — | $0 | 15,300 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-10-14 | 2021-10-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-10-14 | 2021-10-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 201,800 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2021-04-19 | 2021-04-20 | 201,800 | — | $0 | 201,800 | SEC↗ |